Biology PhD Jobs in India at TotipotentRX Cellular Medicine

TotipotentRX Cellular Medicine™ a global leader in the field of stem cells and regenerative medicine therapies based in Los Angeles (USA) and New Delhi focuses in developing, marketing, and selling cellular therapies and treatment techniques for improving hospital and out-patient regenerative medicine programs. This includes developing and commercializing hospital-based GMP clinical trial and biobanking services, and proprietary bedside treatments for both acute and chronic diseases. Our new state of the art cGMP Cell therapy facility seeks highly motivated, intellectually curious, passionate and independent scientists to join our research team.Job Description : Perform duties as a Ph.D. level scientist in the clinical cellular therapy program and GMP laboratory of TotipotentRX.
Desired Profile :Requirements : Education and ExperienceThe position is in the field of regenerative medicine (clinical research) and stem cell biology, and is a great opportunity for a motivated individual interested in gaining experience, technical expertise and a publication record for a career in cutting edge research.Education:We are seeking PhD-level scientists with a background in cellular/developmental biology or immunology. The candidates must have at least 2+ years of research experience in an academic or R&D environment. Post-Doctoral experience is preferable as is GMP compliance.Demonstrated Intellectual Performance:Successful candidates must have a commitment to the field of regenerative medicine as demonstrated by publication authorship.Experience : 2 - 5 YearsEducation : B.Sc - Bio-Chemistry, Bio-Technology | M.Sc Biology, Bio-Chemistry, Bio-Technology, MicrobiologyLocation : GurgaonContact :TotipotentRX Cell Therapy Pvt Ltd
Website : http://.totipotentrx.com
Executive Name :Dr. Venkatesh Ponemone
Address:
Center for Cellular Medicine
Fortis Hospital- Gurgaon
Sector 44 (Adjacent HUDA City Centre Metro Station)
GURGAON,Haryana,India 122002
Email Address : hrindia@totipotentrx.comDeadline : 28.12.11